{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T21:39:51Z","timestamp":1765229991036,"version":"3.46.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,8]]},"DOI":"10.7759\/cureus.98741","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T20:18:07Z","timestamp":1765225087000},"source":"Crossref","is-referenced-by-count":0,"title":["Safety of Clomiphene Citrate and Its Impact on Serum Tumor Markers in Hypogonadal Testicular Cancer Patients After Chemotherapy"],"prefix":"10.7759","author":[{"given":"James","family":"Wren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Myre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua A","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Panken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson E","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E","family":"Brannigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-014-1361-y","article-title":"Increasing incidence of testicular cancer in the United States and Europe between 1992 and 2009","volume":"33","author":"Nigam M","year":"2015","unstructured":"Nigam M, Aschebrook-Kilfoy B, Shikanov S, Eggener S. Increasing incidence of testicular cancer in the United States and Europe between 1992 and 2009. World J Urol. 2015, 33:623-31. 10.1007\/s00345-014-1361-y","journal-title":"World J Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2018.7109","article-title":"Adverse health outcomes in relationship to hypogonadism after chemotherapy: a multicenter study of testicular cancer survivors","volume":"17","author":"Abu Zaid M","year":"2019","unstructured":"Abu Zaid M, Dinh PC Jr, Monahan PO, et al.. Adverse health outcomes in relationship to hypogonadism after chemotherapy: a multicenter study of testicular cancer survivors. J Natl Compr Canc Netw. 2019, 17:459-68. 10.6004\/jnccn.2018.7109","journal-title":"J Natl Compr Canc Netw"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2018.03.115","article-title":"Evaluation and management of testosterone deficiency: AUA guideline","volume":"200","author":"Mulhall JP","year":"2018","unstructured":"Mulhall JP, Trost LW, Brannigan RE, et al.. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018, 200:423-32. 10.1016\/j.juro.2018.03.115","journal-title":"J Urol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/sm2.76","article-title":"Comparison of the effects of testosterone gels, injections, and pellets on serum hormones, erythrocytosis, lipids, and prostate-specific antigen","volume":"3","author":"Pastuszak AW","year":"2015","unstructured":"Pastuszak AW, Gomez LP, Scovell JM, Khera M, Lamb DJ, Lipshultz LI. Comparison of the effects of testosterone gels, injections, and pellets on serum hormones, erythrocytosis, lipids, and prostate-specific antigen. Sex Med. 2015, 3:165-73. 10.1002\/sm2.76","journal-title":"Sex Med"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1016\/S0015-0282(16)35106-8","article-title":"Effect of clomiphene citrate on spermatogenesis in the human: a preliminary report","volume":"15","author":"Jungck EC","year":"1964","unstructured":"Jungck EC, Roy S, Greenblatt RB, Mahesh VB. Effect of clomiphene citrate on spermatogenesis in the human: a preliminary report. Fertil Steril. 1964, 15:40-3.","journal-title":"Fertil Steril"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/andr.13388","article-title":"Clomiphene citrate for male infertility: a systematic review and meta-analysis","volume":"11","author":"Huijben M","year":"2023","unstructured":"Huijben M, Huijsmans RL, Lock MT, de Kemp VF, de Kort LM, van Breda JH. Clomiphene citrate for male infertility: a systematic review and meta-analysis. Andrology. 2023, 11:987-96. 10.1111\/andr.13388","journal-title":"Andrology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2009.01454.x","article-title":"Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: efficacy and treatment cost","volume":"7","author":"Taylor F","year":"2010","unstructured":"Taylor F, Levine L. Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: efficacy and treatment cost. J Sex Med. 2010, 7:269-76. 10.1111\/j.1743-6109.2009.01454.x","journal-title":"J Sex Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19871115)60:10<2489::aid-cncr2820601024>3.0.co;2-b","article-title":"False elevations of human chorionic gonadotropin associated to iatrogenic hypogonadism in gonadal germ cell tumors","volume":"60","author":"Germa JR","year":"1987","unstructured":"Germa JR, Arcusa A, Casamitjana R. False elevations of human chorionic gonadotropin associated to iatrogenic hypogonadism in gonadal germ cell tumors. Cancer. 1987, 60:2489-93. 10.1002\/1097-0142(19871115)60:10&lt;2489::aid-cncr2820601024&gt;3.0.co;2-b","journal-title":"Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.0896","article-title":"Testicular cancer: a reflection on 50 years of discovery","volume":"32","author":"Hanna N","year":"2014","unstructured":"Hanna N, Einhorn LH. Testicular cancer: a reflection on 50 years of discovery. J Clin Oncol. 2014, 32:3085-92. 10.1200\/JCO.2014.56.0896","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22001","article-title":"Patient attitudes toward fertility preservation","volume":"53","author":"Schover LR","year":"2009","unstructured":"Schover LR. Patient attitudes toward fertility preservation. Pediatr Blood Cancer. 2009, 53:281-4. 10.1002\/pbc.22001","journal-title":"Pediatr Blood Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.soncn.2009.08.004","article-title":"Psychosocial distress in young cancer survivors","volume":"25","author":"Rosen A","year":"2009","unstructured":"Rosen A, Rodriguez-Wallberg KA, Rosenzweig L. Psychosocial distress in young cancer survivors. Semin Oncol Nurs. 2009, 25:268-77. 10.1016\/j.soncn.2009.08.004","journal-title":"Semin Oncol Nurs"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2020.11.015","article-title":"Diagnosis and treatment of infertility in men: AUA\/ASRM guideline part I","volume":"115","author":"Schlegel PN","year":"2021","unstructured":"Schlegel PN, Sigman M, Collura B, et al.. Diagnosis and treatment of infertility in men: AUA\/ASRM guideline part I. Fertil Steril. 2021, 115:54-61. 10.1016\/j.fertnstert.2020.11.015","journal-title":"Fertil Steril"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001520","article-title":"Diagnosis and treatment of infertility in men: AUA\/ASRM guideline PART II","volume":"205","author":"Schlegel PN","year":"2021","unstructured":"Schlegel PN, Sigman M, Collura B, et al.. Diagnosis and treatment of infertility in men: AUA\/ASRM guideline PART II. J Urol. 2021, 205:44-51. 10.1097\/JU.0000000000001520","journal-title":"J Urol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2013.09.003","article-title":"Testosterone use in the male infertility population: prescribing patterns and effects on semen and hormonal parameters","volume":"101","author":"Samplaski MK","year":"2014","unstructured":"Samplaski MK, Loai Y, Wong K, Lo KC, Grober ED, Jarvi KA. Testosterone use in the male infertility population: prescribing patterns and effects on semen and hormonal parameters. Fertil Steril. 2014, 101:64-9. 10.1016\/j.fertnstert.2013.09.003","journal-title":"Fertil Steril"},{"key":"ref15","article-title":"Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility","volume":"336","year":"1990","unstructured":"Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility. Lancet. 1990, 336.955-9.","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000396","article-title":"Long-term safety and efficacy of clomiphene citrate for the treatment of hypogonadism","volume":"202","author":"Krzastek SC","year":"2019","unstructured":"Krzastek SC, Sharma D, Abdullah N, et al.. Long-term safety and efficacy of clomiphene citrate for the treatment of hypogonadism. J Urol. 2019, 202:1029-35. 10.1097\/JU.0000000000000396","journal-title":"J Urol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.10.6078","article-title":"Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men","volume":"84","author":"Dobs AS","year":"1999","unstructured":"Dobs AS, Meikle AW, Arver S, Sanders SW, Caramelli KE, Mazer NA. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. J Clin Endocrinol Metab. 1999, 84:3469-78. 10.1210\/jcem.84.10.6078","journal-title":"J Clin Endocrinol Metab"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.10.068","article-title":"A comparison of secondary polycythemia in hypogonadal men\u00a0treated with clomiphene citrate versus testosterone replacement: a multi-institutional study","volume":"197","author":"Wheeler KM","year":"2017","unstructured":"Wheeler KM, Smith RP, Kumar RA, Setia S, Costabile RA, Kavoussi PK. A comparison of secondary polycythemia in hypogonadal men\u00a0treated with clomiphene citrate versus testosterone replacement: a multi-institutional study. J Urol. 2017, 197:1127-31. 10.1016\/j.juro.2016.10.068","journal-title":"J Urol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03744.x","article-title":"Randomized cross-over clinical trial of injectable vs. implantable depot testosterone for maintenance of testosterone replacement therapy in androgen deficient men","volume":"73","author":"Fennell C","year":"2010","unstructured":"Fennell C, Sartorius G, Ly LP, Turner L, Liu PY, Conway AJ, Handelsman DJ. Randomized cross-over clinical trial of injectable vs. implantable depot testosterone for maintenance of testosterone replacement therapy in androgen deficient men. Clin Endocrinol (Oxf). 2010, 73:102-9. 10.1111\/j.1365-2265.2009.03744.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820101)49:1<136::aid-cncr2820490126>3.0.co;2-s","article-title":"Commercial radioimmunoassay for beta subunit of human chorionic gonadotropin: falsely positive determinations due to elevated serum luteinizing hormone","volume":"49","author":"Fowler JE Jr","year":"1982","unstructured":"Fowler JE Jr, Platoff GE, Kubrock CA, Stutzman RE. Commercial radioimmunoassay for beta subunit of human chorionic gonadotropin: falsely positive determinations due to elevated serum luteinizing hormone. Cancer. 1982, 49:136-9. 10.1002\/1097-0142(19820101)49:1&lt;136::aid-cncr2820490126&gt;3.0.co;2-s","journal-title":"Cancer"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.1.239","article-title":"Fertility after chemotherapy for testicular germ cell cancers","volume":"15","author":"Lampe H","year":"1997","unstructured":"Lampe H, Horwich A, Norman A, Nicholls J, Dearnaley DP. Fertility after chemotherapy for testicular germ cell cancers. J Clin Oncol. 1997, 15:239-45. 10.1200\/JCO.1997.15.1.239","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/414459-safety-of-clomiphene-citrate-and-its-impact-on-serum-tumor-markers-in-hypogonadal-testicular-cancer-patients-after-chemotherapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T20:18:07Z","timestamp":1765225087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/414459-safety-of-clomiphene-citrate-and-its-impact-on-serum-tumor-markers-in-hypogonadal-testicular-cancer-patients-after-chemotherapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.98741","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,8]]}}}